(firstQuint)Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder.

 This is a 14 week randomized open study of 50 inpatients or outpatients with bipolar I r II.

 African American subjects will receive lithium or depakote ER.

 Measures will be made of psychopathology, reported side effects, and study completers.

 Measures will also be made of RBC/plasma lithium to determine if this level is better predictive of lithium tolerability.

.

 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder@highlight

It is hypothesized that Depakote will be better tolerated then lithium in treating African Americans with bipolar disorder.

